| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $125.6M | +34.9% |
| R&D Expense | $322.4M | -4.8% |
| SG&A Expense | $213.9M | +6.8% |
| Operating Income | -$2.19B | -44.5% |
| Pre-tax Income | -$2.16B | -43.4% |
| Income Tax | -$135.4M | -222.7% |
| Net Income | -$2.03B | -38.3% |
| EPS (Basic) | -$63.54 | -34.6% |
| EPS (Diluted) | -$63.54 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.2M | +120.2% |
| Accounts Receivable | $20.3M | +19.9% |
| Current Assets | $819.9M | +425.3% |
| Total Assets | $2.98B | -23.8% |
| Current Liabilities | $76.9M | -53.0% |
| Total Liabilities | $479.9M | +79.3% |
| Stockholders' Equity | $2.50B | -31.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$577.2M | +3.1% |
| Capital Expenditures | $5.2M | -59.6% |
| Investing Cash Flow | -$551.0M | -4175.7% |
| Financing Cash Flow | $1.24B | +168.3% |
| Free Cash Flow | -$582.4M | +4.3% |
| -34.6% |